PUBLISHER: SkyQuest | PRODUCT CODE: 1205830
PUBLISHER: SkyQuest | PRODUCT CODE: 1205830
Cancer Immunotherapy Market By cancer type, By product, By end use, By route of administration, & By region-Forecast Analysis 2022-2028
Global Cancer Immunotherapy Market was valued at USD 118.29 billion in 2021 and it is expected to reach a value of USD 292.3 billion by 2028, at a CAGR of 13.8% over the forecast period (2022-2028).
The primary factors driving the market are an increase in oncology incidence around the world and a spike in R&D efforts for the creation of novel oncology treatments. Additionally, a number of organizations that fund immunotherapy research exist, which is anticipated to assist market expansion. For instance, to create innovative immune medicines for cancer, the Parker Institute for Cancer Immunotherapy worked with scientists and business pioneers.
Top-down and bottom-up approaches were used to estimate and validate the size of the global cancer immunotherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
Global cancer immunotherapy market is segmented on the basis of product, cancer type, route of administration, end-user, and region. By product, the market is segmented into monoclonal antibodies, immunomodulators, and cancer vaccines. By route of administration, the market is segmented into oral, parenteral, and others. By end-user, the market is segmented into hospitals, homecare, specialty centers, others. By cancer type, the market is categorized into lung cancer, breast cancer, colorectal cancer, prostate cancer, and others. By region, the market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.
Driver
The expansion of the market is being aided by the existence of numerous government and non-government organizations that raise awareness and support research. For instance, the Cancer Research Institute spent almost USD 474 million on research while supporting more than 120 clinical trials. Additionally, the Society for Immunotherapy of Cancer (SITC) is working to advance the understanding and use of oncology immunotherapy in order to improve patient outcomes. These organizations are collaborating with scientists and researchers to develop cutting-edge immune therapy treatment plans.
Restraint
The main factor projected to restrain the growth of the global cancer immunotherapy market over the forecast period is high manufacturing costs as well as high prices for end users. The market's growth is anticipated to slow down in the upcoming years due to the significant resources and high investment needed for treatment enhancement and development.
Market Trends
Research and development efforts to create cancer immunotherapy are anticipated to increase with increased financing for the development of innovative therapies. For instance, the U.S. National Cancer Institute and Cancer Research UK's Cancer Grand Challenges project provided USD 13 million in funding to a team of Stanford scientists in June 2022. The creation of new immunotherapies, research into extrachromosomal DNA, and examination of early-stage cancers are all recipients of this money.
Table of Contents
Executive Summary
Market overview
- Exhibit: Executive Summary - Chart on Market Overview
- Exhibit: Executive Summary - Data Table on Market Overview
- Exhibit: Executive Summary - Chart on Global Cancer Immunotherapy Market Characteristics
- Exhibit: Executive Summary - Chart on Market by Geography
- Exhibit: Executive Summary - Chart on Market Segmentation
- Exhibit: Executive Summary - Chart on Incremental Growth
- Exhibit: Executive Summary - Data Table on Incremental Growth
- Exhibit: Executive Summary - Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy-scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Cancer Immunotherapy Market size and forecast 2022-2028 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2022-2028 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Cancer Immunotherapy Market by Product
- Market segments
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Data table on Market share 2022-2028 (%)
- Monoclonal Antibodies
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Immunomodulators
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Cancer Vaccines
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Global Cancer Immunotherapy Market by Cancer Type
- Market segments
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Data table on Market share 2022-2028 (%)
- Lung Cancer
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Breast Cancer
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Colorectal Cancer
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Prostate Cancer
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- others
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Global Cancer Immunotherapy Market by End-User
- Market segments
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Data table on Market share 2022-2028 (%)
- Hospitals
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Homecare
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Speciality Centres
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Others
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Global Cancer Immunotherapy Market by Route of Administration
- Market segments
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Data table on Market share 2022-2028 (%)
- Oral
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Parenteral
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Others
- Market Estimates & Forecast, 2021-2028
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
Market Size by Region
- Chart on Market share by geography 2022-2028 (%)
- Data Table on Market share by geography 2022-2028(%)
- North America
- Chart on Market share by country 2022-2028 (%)
- Data Table on Market share by country 2022-2028(%)
- USA
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Canada
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Europe
- Chart on Market share by country 2022-2028 (%)
- Data Table on Market share by country 2022-2028(%)
- Germany
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Spain
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- France
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- UK
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Asia Pacific
- Chart on Market share by country 2022-2028 (%)
- Data Table on Market share by country 2022-2028(%)
- China
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- India
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Japan
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- South Korea
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Latin America
- Chart on Market share by country 2022-2028 (%)
- Data Table on Market share by country 2022-2028(%)
- Brazil
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2022-2028 (%)
- Data Table on Market share by country 2022-2028(%)
- GCC Countries
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- South Africa
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2022-2028 (%)
- Exhibit: Market size and forecast 2022-2028 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
